ImmuneXcite Secures $2,418,788 New Funding

  • Feed Type
  • Date
    1/5/2012
  • Company Name
    ImmuneXcite
  • Mailing Address
    64 Grove Street Watertown, MA 02472
  • Company Description
    ImmuneXcite has developed a proprietary platform technology for enhancing the efficacy of therapeutic monoclonal antibodies for oncological and infectious disease targets.
  • Website
    http://www.immunexcite.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,418,788
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed